Unichem Laboratories shareholders and shareholding pattern
NSE: UNICHEMLABBSE: 506690Pharmaceuticals & BiotechnologySmall Cap
Last close ₹472.95down ₹14.80 (3.03%)BSE ₹471.95
Share price at the NSE close on 23 Oct 2026. Previous close ₹487.75.
52-week range of traded prices to 23 Oct 2026
₹278.20Low, 30 Mar 2026₹687.20High, 9 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3,330 Cr1,036th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 10.9
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 33.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 22 May 2026
- 1.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 11.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 22 May 2026
- 0.17
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 40,08440.7% delivered
Who owns Unichem Laboratories, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters70.22%
- Foreign institutions2.70%
- Indian institutions9.40%
- Individuals and others17.68%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Dec 2016Filed 9 Jan | Mar 2017Filed 11 Apr | Jun 2017Filed 11 Jul | Sep 2017Filed 12 Oct | Dec 2017Filed 15 Jan | Mar 2018Filed 18 Apr | Jun 2018Filed 13 Jul | Sep 2018Filed 19 Oct | Dec 2018Filed 11 Jan | Mar 2019Filed 18 Apr | Jun 2019Filed 11 Jul | Sep 2019Filed 10 Oct | Dec 2019Filed 10 Jan | Mar 2020Filed 21 Apr | Jun 2020Filed 14 Jul | Sep 2020Filed 12 Oct | Dec 2020Filed 14 Jan | Mar 2021Filed 16 Apr | Jun 2021Filed 12 Jul | Sep 2021Filed 12 Oct | Dec 2021Filed 12 Jan | Mar 2022Filed 11 Apr | Jun 2022Filed 18 Jul | Sep 2022Filed 14 Oct | Dec 2022Filed 12 Jan | Mar 2023Filed 12 Apr | Jun 2023Filed 15 Jul | Sep 2023Filed 16 Oct | Dec 2023Filed 10 Jan | Mar 2024Filed 12 Apr | Jun 2024Filed 16 Jul | Sep 2024Filed 11 Oct | Dec 2024Filed 9 Jan | Mar 2025Filed 9 Apr | Jun 2025Filed 19 Jul | Sep 2025Filed 15 Oct | Dec 2025Filed 9 Jan | Mar 2026Filed 13 Apr | Jun 2026Filed 14 Jul | Sep 2026Filed 13 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.08% | 50.08% | 50.06% | 50.06% | 50.05% | 50.67% | 50.67% | 50.67% | 50.64% | 50.64% | 50.62% | 50.62% | 50.62% | 50.74% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 70.21% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | |
| Indian promoters | 50.08% | 50.08% | 50.06% | 50.06% | 50.05% | 50.67% | 50.67% | 50.67% | 50.64% | 50.64% | 50.62% | 50.62% | 50.62% | 50.74% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 50.93% | 70.21% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 49.92% | 49.92% | 49.94% | 49.94% | 49.95% | 49.33% | 49.33% | 49.33% | 49.36% | 49.36% | 49.38% | 49.38% | 49.38% | 49.26% | 49.07% | 49.07% | 49.07% | 49.07% | 49.07% | 49.07% | 49.07% | 49.07% | 49.07% | 49.07% | 49.07% | 49.07% | 49.07% | 29.79% | 29.78% | 29.78% | 29.78% | 29.78% | 29.78% | 29.78% | 29.78% | 29.78% | 29.78% | 29.78% | 29.78% | 29.78% |
| Shares in issue | 9,08,74,500 | 9,08,76,525 | 9,09,19,200 | 9,09,19,200 | 9,09,36,000 | 7,03,37,000 | 7,03,37,000 | 7,03,43,075 | 7,03,83,250 | 7,03,83,250 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 | 7,04,05,750 |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Unichem Laboratories promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Ipca Laboratories Limited, 52.67%.Promoter buying and selling
| Holder | ||
|---|---|---|
| Ipca Laboratories LimitedIndian companies, trusts and others | 52.67% | 3,70,81,011 |
| Dr. Prakash Amrut ModyIndividuals and Hindu undivided families | 12.78% | 89,97,952 |
| Anita Prakash ModyIndividuals and Hindu undivided families | 1.88% | 13,23,400 |
| Supriya Prakash ModyIndividuals and Hindu undivided families | 1.35% | 9,49,936 |
| Suparna Prakash ModyIndividuals and Hindu undivided families | 1.35% | 9,49,936 |
| Dr. Prakash Amrut Mody - Suparna Mody Trust (Promoter Trust )Indian companies, trusts and others | 0.07% | 52,016 |
| Dr. Prakash Amrut Mody - Shwetambari Mody Trust (Promoter Trust)Indian companies, trusts and others | 0.06% | 41,283 |
| Dr. Prakash Amrut Mody - Supriya Mody Trust (Promoter Trust)Indian companies, trusts and others | 0.06% | 45,052 |
No promoter shares are reported as pledged.
Largest public holders of Unichem Laboratories, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016Filed 9 Jan | Mar 2017Filed 11 Apr | Jun 2017Filed 11 Jul | Sep 2017Filed 12 Oct | Dec 2017Filed 15 Jan | Mar 2018Filed 18 Apr | Jun 2018Filed 13 Jul | Sep 2018Filed 19 Oct | Dec 2018Filed 11 Jan | Mar 2019Filed 18 Apr | Jun 2019Filed 11 Jul | Sep 2019Filed 10 Oct | Dec 2019Filed 10 Jan | Mar 2020Filed 21 Apr | Jun 2020Filed 14 Jul | Sep 2020Filed 12 Oct | Dec 2020Filed 14 Jan | Mar 2021Filed 16 Apr | Jun 2021Filed 12 Jul | Sep 2021Filed 12 Oct | Dec 2021Filed 12 Jan | Mar 2022Filed 11 Apr | Jun 2022Filed 18 Jul | Sep 2022Filed 14 Oct | Dec 2022Filed 12 Jan | Mar 2023Filed 12 Apr | Jun 2023Filed 15 Jul | Sep 2023Filed 16 Oct | Dec 2023Filed 10 Jan | Mar 2024Filed 12 Apr | Jun 2024Filed 16 Jul | Sep 2024Filed 11 Oct | Dec 2024Filed 9 Jan | Mar 2025Filed 9 Apr | Jun 2025Filed 19 Jul | Sep 2025Filed 15 Oct | Dec 2025Filed 9 Jan | Mar 2026Filed 13 Apr | Jun 2026Filed 14 Jul | Sep 2026Filed 13 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Polunin Emerging Markets Small Cap Fund, LlcForeign portfolio investors, category II | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.58% |
| Investor Education and Protection Fund Authority Ministry of Corporate AffairsInvestor education fund | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.06% | 1.06% | 1.09% | 1.09% | 1.07% | 1.04% | 1.06% |
| Investor Education and Protection Fund Authority Ministry of Corporate Affairs nInvestor education fund | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.06% | – | – | – | – | – | – | – | – |
| Krishnaraj VenkataramanResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | 1.02% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| DSP AIF PHARMA FUNDAlternative investment funds | – | – | – | – | – | – | – | 1.16% | 1.16% | 1.16% | 1.16% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Sanghvi Finance Private LtdOther non-institutions | – | – | – | – | – | – | – | – | – | 1.65% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Government Pension Fund GlobalInstitutions Foreign Portfolio Investor | – | – | – | – | 2.13% | 2.65% | 2.62% | 1.85% | 1.85% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Alrox Investment and Finance Pvt LtdOther non-institutions | – | – | – | – | 1.76% | 1.42% | 1.42% | 1.42% | 1.42% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Family Investment Pvt LtdOther non-institutions | – | – | – | – | 1.58% | 1.28% | 1.28% | 1.28% | 1.02% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| General Insurance Corporation of IndiaInsurance companies | 1.65% | 1.65% | 1.65% | 1.65% | 1.65% | 1.53% | 1.53% | 1.21% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Airborn Investment and Finance Pvt LtdOther non-institutions | – | – | – | – | – | – | 1.02% | 1.02% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Dsp Blackrock Aif Pharma FundAlternative investment funds | – | – | 1.14% | 1.22% | 1.47% | 1.13% | 1.16% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Airborne Investment and Finance Pvt. Ltd.Other non-institutions | – | – | – | – | 1.26% | 1.02% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Nordea 1 Sicav Indian Equity FundInstitutions Foreign Portfolio Investor | 1.15% | 1.22% | 1.33% | 1.34% | 1.47% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.